Home Other Building Blocks 94424-50-7
94424-50-7,MFCD00893553
Catalog No.:AA019FPR

94424-50-7 | Quinagolide hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
1 week  
$558.00   $391.00
- +
10mg
1 week  
$860.00   $602.00
- +
50mg
1 week  
$2,273.00   $1,591.00
- +
100mg
1 week  
$3,066.00   $2,147.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA019FPR
Chemical Name:
Quinagolide hydrochloride
CAS Number:
94424-50-7
Molecular Formula:
C20H34ClN3O3S
Molecular Weight:
432.0203
MDL Number:
MFCD00893553
SMILES:
CCCN1C[C@@H](C[C@@H]2[C@@H]1Cc1cccc(c1C2)O)NS(=O)(=O)N(CC)CC.Cl
Properties
Computed Properties
 
Complexity:
576  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
3  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
7  

Literature

Title: New developments on the galactopoietic role of prolactin in dairy ruminants.

Journal: Domestic animal endocrinology 20120801

Title: Hypogonadism secondary to hyperprolactinaemia: successful treatment but adverse consequences.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20120501

Title: Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.

Journal: Pituitary 20120301

Title: A sequence of pathologic events in a patient after thymectomy for myasthenia gravis.

Journal: Rheumatology international 20120101

Title: The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.

Journal: General hospital psychiatry 20120101

Title: Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders.

Journal: Neuro endocrinology letters 20120101

Title: Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia.

Journal: Fertility and sterility 20110301

Title: Effect of the prolactin-release inhibitor quinagolide on lactating dairy cows.

Journal: Journal of dairy science 20110301

Title: Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas.

Journal: Clinical neuropharmacology 20110101

Title: Treating prolactinoma and psychosis: medication and cognitive behavioural therapy.

Journal: BMJ case reports 20110101

Title: Prolactinomas and pregnancy.

Journal: Clinical endocrinology 20100801

Title: [Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide].

Journal: Orvosi hetilap 20100627

Title: Efficacy of Ovsynch protocol with antiprolactin treatment for timed artificial insemination during non-breeding seasons in yaks (Poephagus grunniens L.).

Journal: Reproduction in domestic animals = Zuchthygiene 20100601

Title: The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial.

Journal: Human reproduction (Oxford, England) 20100401

Title: [Treatment of pituitary adenomas].

Journal: Orvosi hetilap 20090927

Title: Plasma progesterone, oestradiol-17β and total oestrogen profiles in relation to oestrous behaviour during induced ovulation in Murrah buffalo heifers.

Journal: Journal of animal physiology and animal nutrition 20090801

Title: Changes in endocrine profiles during ovsynch and ovsynch plus norprolac treatment in Murrah buffalo heifers at hot summer season.

Journal: Tropical animal health and production 20090401

Title: Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy.

Journal: The Journal of clinical endocrinology and metabolism 20080401

Title: [Some issues in the diagnosis and treatment of hyperprolactinemia].

Journal: Zhonghua fu chan ke za zhi 20080401

Title: Development and validation of a simple, sensitive enzyme immunoassay (EIA) for quantification of prolactin in buffalo plasma.

Journal: Theriogenology 20070201

Title: Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.

Journal: Autoimmunity 20070201

Title: Prolactin and autoimmune diseases in humans.

Journal: Acta bio-medica : Atenei Parmensis 20070101

Title: Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

Journal: Pituitary 20070101

Title: A case of mania after long-term use of quinagolide.

Journal: General hospital psychiatry 20070101

Title: Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?

Journal: European journal of endocrinology 20061101

Title: Current treatment issues in female hyperprolactinaemia.

Journal: European journal of obstetrics, gynecology, and reproductive biology 20060401

Title: Quinagolide--a valuable treatment option for hyperprolactinaemia.

Journal: European journal of endocrinology 20060201

Title: [Hyperprolactinemia: causes, diagnosis, and treatment].

Journal: Endokrynologia Polska 20060101

Title: The clinical characteristics of headache in patients with pituitary tumours.

Journal: Brain : a journal of neurology 20050801

Title: Prolactinomas and pregnancy.

Journal: Pituitary 20050101

Title: [Prolactinoma and pregnancy].

Journal: Akusherstvo i ginekologiia 20040101

Title: Dopamine agonist therapy for hyperprolactinemia.

Journal: Clinical obstetrics and gynecology 20030601

Title: An investigation of the effectiveness of testosterone implants in combination with the prolactin inhibitor quinagolide in the suppression of spermatogenesis in men.

Journal: Human reproduction (Oxford, England) 20030401

Title: Tissue-polypeptide-specific antigen in SLE patients treated with low doses of quinagolide.

Journal: Lupus 20030101

Title: Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.

Journal: The Journal of clinical endocrinology and metabolism 20021201

Title: A preliminary study of dopamine-mediated prolactin inhibition in generalised social phobia.

Journal: Psychiatry research 20020805

Title: Dopamine receptor agonists for treating prolactinomas.

Journal: Expert opinion on investigational drugs 20020601

Title: The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors.

Journal: Annals of the New York Academy of Sciences 20020601

Title: [Novel pharmacologic therapies in acromegaly].

Journal: Orvosi hetilap 20020512

Title: Spectrophotometric determination of clobetasol propionate, halobetasol propionate, quinagolide hydrochloride, through charge transfer complexation.

Journal: Journal of pharmaceutical and biomedical analysis 20020301

Title: MR imaging of pituitary adenomas treated with the prolactin inhibitor quinagolide.

Journal: Acta radiologica (Stockholm, Sweden : 1987) 20020301

Title: [A 50-year old patient with macroprolactinoma].

Journal: Praxis 20020109

Title: A luteinizing hormone-, alpha-subunit- and prolactin-secreting pituitary adenoma responsive to somatostatin analogs: in vivo and in vitro studies.

Journal: European journal of endocrinology 20010701

Title: [Efficacy of quinagolide in the treatment of a patient with hypophyseal resistance to thyroid hormones].

Journal: Anales de medicina interna (Madrid, Spain : 1984) 20010501

Title: In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.

Journal: Clinical endocrinology 20010401

Title: Selected serum cytokines in systemic lupus erythematosus treated with quinagolide.

Journal: Lupus 20010101

Title: Quinagolide in the management of prolactinoma.

Journal: Pituitary 20001201

Title: The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.

Journal: Clinical endocrinology 20000701

Title: Mostafa AA, et al. Spectrophotometric determination of clobetasol propionate, halobetasol propionate, quinagolide hydrochloride, through charge transfer complexation. J Pharm Biomed Anal. 2002 Mar 1;27(6):889-899.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 94424-50-7
Tags:94424-50-7 Molecular Formula|94424-50-7 MDL|94424-50-7 SMILES|94424-50-7 Quinagolide hydrochloride